Trial Profile
Phase I/II study of adjuvant therapy after liver transplantation in the recipients with advanced hepoatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Jun 2011
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Interferon (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 03 Jun 2011 New trial record